Home
>
National Drug Code (NDC)
>
Estropipate
Estropipate - 0591-0415-30 - (Estropipate)
Drug Information of Estropipate
| Product NDC: | 0591-0415 |
| Proprietary Name: | Estropipate |
| Non Proprietary Name: | Estropipate |
| Active Ingredient(s): | 1.5 mg/1 & nbsp; Estropipate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Estropipate
| Product NDC: | 0591-0415 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA081214 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19930923 |
Package Information of Estropipate
| Package NDC: | 0591-0415-30 |
| Package Description: | 30 TABLET in 1 BOTTLE, PLASTIC (0591-0415-30) |
NDC Information of Estropipate
| NDC Code | 0591-0415-30 |
| Proprietary Name | Estropipate |
| Package Description | 30 TABLET in 1 BOTTLE, PLASTIC (0591-0415-30) |
| Product NDC | 0591-0415 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Estropipate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19930923 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | ESTROPIPATE |
| Strength Number | 1.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
